To examine the impact of body mass index (BMI) upon medical care use and its costs in Japan. DESIGN: A population-based prospective cohort study from 1995 to 1998. SUBJECTS: A cohort of 41 967 Japanese adults aged 40 -79 y. Subjects who died during the first year of follow-up, or who at baseline reported having had cancer, myocardial infarction, stroke or kidney disease were excluded. MEASUREMENTS: Medical care use and its costs, actual charges, by linkage with the National Health Insurance claim history files after adjustment of smoking, drinking and physical functioning status. RESULTS: There was a U-shaped association between BMI and total medical costs. The nadir of the curve was found at a BMI of 21.0 -22.9 kg=m 2 . Relative to the nadir, total costs were 9.8% greater among those with BMIs of 25.0 -29.9 (rate ratio, 1.10; 95% confidence interval (CI), 1.03 -1.17), and 22.3% greater among those with BMIs of 30.0 or higher (rate ratio, 1.22; 95% CI, 1.08 -1.37). Estimated excess direct costs attributable to overweight (BMI of 25.0 -29.9 kg=m 2 ) and obesity (BMI of 30.0 kg=m 2 or higher) represent 3.2% of total health expenditure in the present study, which is within the range reported in Western countries (0.7 -6.8%). CONCLUSION: Our prospective data demonstrate that the impact of overweight and obesity upon medical care costs in Japan is as large as in Western countries, despite the much lower mean BMI in Japanese populations.
Introduction
Accumulating evidence indicates that obesity is significantly associated with excess medical care costs. However, all of these reports are from Western countries. 1 -16 No data have been reported from Asian countries, including Japan.
Although obesity (body mass index (BMI; kg=m 2 ) of 30.0 or higher) is less prevalent among Japanese (2 -3%) 17 than among Westerners (5 -27%), 18 epidemiological studies have suggested that Japanese people may be more likely to develop adverse effects due to excess weight. For instance, the prevalence of type 2 diabetes, an obesity-related disease, is similar in Japanese (10 -12%) 19 and Western (8 -12%) populations, 20, 21 despite their differing rates of obesity. It would therefore be necessary to examine the degree of excess medical expenditure attributable to obesity in the Japanese population to fully understand the impact of obesity upon societies worldwide.
Furthermore, of 16 previous studies reported to date which examined the association between obesity and medical costs, 14 studies were based on hypothetical, crosssectional, or retrospective study designs. 1 -11,14 -16 The remaining two studies were based on prospective cohort design, which had 1.0 and 1.5 y observational periods. 12, 13 We conducted a 4 y (the longest follow-up period among the previous prospective studies) population-based prospective cohort study of 41 967 Japanese adults (Ohsaki cohort) to examine the impact of BMI on medical care use and its costs (actual charges) in Japan. In this paper, we classified 'overweight' as a BMI of 25.0 -29.9 and 'obese' as BMI of 30.0 or higher.
Methods

Study population
The present data were derived from the Ohsaki National Health Insurance (NHI) beneficiaries cohort study. The subjects were all NHI beneficiaries, aged 40 -79 y, living in the catchment area of Ohsaki Public Health Center, Miyagi Prefecture, northeast Japan. We prospectively collected data on medical care utilization and its costs for all individuals in the cohort between January 1995 and December 1998. The details of the study project and the representativeness of these subjects have been described previously. 22 -24 The study protocol was approved by the Ethics Committee of Tohoku University School of Medicine.
The baseline survey was conducted between October and December 1994. Of 54 996 eligible individuals, 52 029 (95%) responded. We excluded 774 subjects because they had been withdrawn from the NHI before 1 January 1995, when we started prospective collection of NHI claim history files. Thus 51 255 subjects formed the cohort under study.
We excluded the following subjects from analysis in sequence: (1) those who did not provide information about body weight or body height (n ¼ 3543); (2) those at both extremes of the BMI range -lower than the 0.05th percentile for BMI (below 14.41 for men; below 13.67 for women) or higher than the 99.95th percentile for BMI (above 58.46 for men; above 62.00 for women; n ¼ 48); (3) those who died within the first year (n ¼ 454); and (4) those who at baseline reported having had either cancer (n ¼ 1533), myocardial infarction (n ¼ 1233), stroke (n ¼ 831) or kidney disease (n ¼ 1646). Thus, we analyzed 41 967 subjects (20 067 men and 21 900 women).
Body mass index
The baseline survey included questions on body weight and body height, and BMI was calculated as the weight divided by the square of the height (kg=m 2 ). We grouped subjects into the following categories: BMI lower than 18.5, 18.5 -20.9, 21.0 -22.9, 23.0 -24.9, 25.0 -29.9, and 30.0 or higher. Combinations of these categories correspond to the cut-off points proposed by the World Health Organization: normal range (BMI 18.5 -24.9), grade 1 overweight (BMI 25.0 -29.9), grade 2 overweight (BMI 30.0 -39.9), and grade 3 overweight (BMI 40.0 or higher). 25 We evaluated the validity of self-reported body weight and body height. Among the study subjects, 14 883 individuals had their body height and weight measured during basic health examinations provided by local governments in 1995. The Pearson's correlation coefficient (r) of the selfreported and measured values was 0.96 (P < 0.0001) for body weight, 0.93 (P < 0.0001) for body height, and 0.88 (P < 0.0001) for BMI. Thus, self-reported height and weight at this baseline questionnaire were considered to be sufficiently valid.
Health insurance system in Japan Health insurance is compulsory for everyone living in Japan, and consists of two systems. 26 One is the insurance system for employees and their dependents, and the other is a system of community-based health insurance for farmers, self-employed, pensioners and their dependents. The latter system is called the National Health Insurance (NHI) plan and covers 35% of the Japanese population. Payment to medical providers is made on a fee-for-service basis, where the price of each service is determined by a uniform national fee schedule. The NHI covers almost all of medical treatment, including diagnostic tests, medication, surgery, supplies and materials, physicians and other personnel costs, and most of the dental treatment. It also covers home care services provided by physicians and nurses but not those by other professionals such as home health aides. The NHI does not cover nursing home care. NHI files are given by inpatient and outpatient files, respectively.
When a beneficiary is withdrawn from NHI because of death or emigration, the data and reason are entered on the NHI withdrawal history files. Both NHI claims and withdrawal history files were linked with our baseline survey data files with beneficiary ID number as key code.
Statistical analysis
The impact of BMI on per month per capita medical costs (total, inpatient and outpatient), hospital days and number of physician visits was examined by analysis of covariance.
Per month values for each subject were calculated by dividing the accumulated values through observation by the number of months observed. We examined per month values rather than accumulated values to avoid underestimating the medical care use and costs of the subjects who died or emigrated. Tests of linear trends across BMI, where appropriate, were conducted by treating the category as a continuous variable.
Excess medical costs of total health care expenditure attributable to overweight and obesity was calculated as follows: A ¼ (mean total costs for the overweight (BMI of 25.0 -29.9) times the mean number of months observed among the overweight) minus (mean total costs at the nadir times the mean number of months observed at the nadir); B ¼ (mean total costs for the obese (BMI of 30.0 or higher) times the mean number of months observed among the obese) minus (mean total costs at the nadir times the mean number of months observed at the nadir); C ¼ A times the number of subjects who were overweight; D ¼ B times the number of subjects who were obese. The proportion of excess medical costs of total health care expenditure attributable to overweight and obesity is (C þ D)=total medical costs in the present study for 4 y.
In this analysis, we regarded the following data as covariates: sex, age (continuous variable), smoking status (never, ever), alcohol drinking (46 g or more ethanol intake a day, other), and physical function status (MOS scores 0 -1, 2 -4, Medical cost and body mass index in Japan S Kuriyama et al 5 -6). The Medical Outcome Study (MOS) questionnaire assesses the physical function status of each subject by the six-item physical function measure of the MOS Short-form General Health Survey. 27 An MOS score of 0 -1 denotes frail and disabled. An MOS score of 5 -6 denotes ability to undertake moderate to vigorous exercise.
All statistical analysis was performed with SAS. 28 We used approximate variance formulas to calculate the 95% confidence intervals (CI). A level of P < 0.05 was accepted as statistically significant. In this paper, monetary values were converted into US dollars using the rate of US$ 1.00 ¼ 120 Japanese yen.
Results
Baseline characteristics of the subjects Table 1 shows baseline characteristics of the subjects by categories of BMI. The prevalence of overweight (BMI of 25.0 -29.9) or obesity (BMI of 30.0 or higher) were 26.0 and 2.8%, respectively, which was consistent with the Japanese National Nutrition Survey data (BMI 25.0 -29.9, 24.3% in men and 20.2% in women; BMI 30.0 -39.9, 1.84% in men and 2.87% in women). 17 The proportion of women was higher in the lowest and highest BMI levels. Those who had the lowest BMIs had the highest mean ages. Overweight or obese subjects had lower rates of smoking and drinking.
The proportion of those who had limited physical function status was higher among subjects with the highest and lowest BMI levels.
Total medical costs by body mass index levels Table 2 lists adjusted per capita total medical costs by BMI levels. There was a U-shaped association between BMI and total medical costs. Medical costs were lowest at BMIs between 21.0 and 22.9. Relative to the nadir, mean total costs were 9.8% greater among the overweight (rate ratio, 1.10; 95% CI, 1.03 -1.17), and 22.3% greater among the obese (rate ratio, 1.22; 95% CI, 1.08 -1.37).
Overweight and obesity attributable costs A ¼ (mean total costs for the overweight (US$ 197.6) times the mean number of months observed among the overweight (45.7 months)) minus (mean total costs at the nadir (US$ 180.0) times the mean number of months observed at the nadir (45.5 months) ¼ US$ 840.3. B ¼ (mean total costs for the obese (US$ 220.1) times the mean number of months observed among the obese (45.9 months)) minus (mean total costs at the nadir (US$ 180.0) times the mean number of months observed at the nadir (45.5 months) ¼ US$ 1912.6. C ¼ US$ 840.3 times the number of subjects who were over- The proportion of excess costs of total health care expenditure attributable to overweight and obesity in the present study ¼ (C þ D)=total medical costs in the present study for 4 y (US$ 360.8 million) ¼ 0.032 (four-fifths for overweight, one-fifth for obesity).
Inpatient and outpatient medical care expenditures by body mass index levels There was a U-shaped association between BMI and both per capita inpatient medical costs and the mean number of days each person spent in hospital (Figure 1 ). Among those with the highest and lowest BMIs, compared to those with BMIs of 21.0 -22.9, inpatient costs increased by 12.3% (rate ratio, 1.12; 95% CI, 0.84 -1.45) and 43.5% (rate ratio, 1.44; 95% CI, 1.15 -1.76), and mean days for inpatient care increased by 14.0% (rate ratio, 1.14; 95% CI, 0.83 -1.50) and 58.4% (rate ratio, 1.58; 95% CI, 1.27 -1.95), respectively.
A linear association was observed between BMI and outpatient medical care costs and physician visits (P for linear trend < 0.0001; Figure 2 ). Among those with the highest and lowest BMIs, compared to those with BMIs of 21.0 -22.9, outpatient costs increased by 28.5% (rate ratio, 1.29; 95% CI, 1.19 -1.38) and decreased 1.0% (rate ratio, 0.99; 95% CI, 0.91 -1.07), and mean days for outpatient care increased 25.9% (rate ratio, 1.26; 95% CI, 1.17 -1.35) and decreased 3.6% (rate ratio, 0.96; 95% CI, 0.89 -1.04), respectively.
Discussion
We examined the relationship between BMI and medical care expenditure based on a prospective cohort of 41 967 Japanese adults aged 40 -79 y over 4 y. The results demonstrate that there is a U-shaped association between BMI and mean total costs. Relative to the nadir, mean total costs were 9.8% greater among those who were overweight (BMI of 25.0 -29.9) and 22.3% greater among those who were obese (BMI of 30.0 or higher). We estimated the costs of overweight and obesity from the above results to be 3.2% of total costs. This 3.2% is within the range reported in Western studies (0.7 -6.8%), 1 -4,6,10 -12,14,15 although the definition of obesity varied among those studies (BMI of 25.0 or higher to BMI of 30.0 or higher).
Our study had several methodological advantages. We followed up the large number of subjects (n ¼ 41 967). Our cost calculation was accurate because we obtained NHI Claim History files directly from the Miyagi NHI Association, which includes almost all available medical treatment. Our BMI values were considered to be sufficiently valid because of Medical cost and body mass index in Japan S Kuriyama et al the high correlation coefficient between self-reported body weight and height and the measured values. The representativeness of our study subjects was fully confirmed in a previous paper 22 and our study population had a similar range of BMI levels as that of a representative Japanese sample. 17 We analyzed the impact of BMI upon medical care expenditure after adjustment of a variety of other lifestyle indicators such as smoking, drinking and physical functioning status.
Our study had some limitations. Although our 4 y followup period was longer than previous studies, and we excluded subjects who might have had great weight changes prior to the baseline survey to reduce the potential bias in estimates of the impact of BMI upon medical care costs, it is apparently not sufficient to avoid fully the effect of confounding weight changes prior to the baseline survey of the subjects. These weight reductions caused by preexisting or occult diseases might therefore contribute to underestimating the true costs of the higher BMI group and overestimating those of the lower BMI group. Second, like most other studies, we did not monitor changes in our subject's body weight during the period when medical costs were followed up. As the body weight varies with time, we might have misclassified the BMI for some of the subjects. However, because the follow-up period was 4 y, the extent of the misclassification bias would not be serious.
Another concern is that we had no measure of central adiposity, such as the ratio of waist circumference to hip circumference. Because greater visceral adiposity is a better predictor of the risk of diabetes or death than the BMI, 29, 30 measurement of central adiposity would be needed in further studies to estimate the impact of obesity upon medical care expenditure.
Of the two previous studies examining the relationship between BMI and medical costs based on a prospective cohort design, 12, 13 Quesenberry et al 12 reported that among Western populations, relative to BMI of 20.0 -24.9, mean annual total costs were 25% greater (BMI of 30.0 -34.9) and 5% smaller (BMI of 25.0 -29.9). Our data indicates that relative to BMI of 21.0 -22.9, mean total costs were 22.3% greater (BMI of 30.0 or higher) and 9.8% greater (BMI of 25.0 -29.9). Our results among the overweight (BMI of 25.0 -29.9) were not consistent with those of Quesenberry, although our results among the obese (BMI of 30.0 or higher) were consistent. This inconsistency might partly be explained by the hypothesis that Japanese people may be more likely to develop adverse effects due to excess weight than Western populations. It may be beneficial to direct intervention to the overweight, that is, the pre-obese, to encourage them to reduce their weight.
We also demonstrated that both inpatient and outpatient use was high for subjects with higher BMIs. Subjects with lower BMIs, however, had relatively low outpatient use compared to their inpatient use, despite the apparent link between lower BMI and pre-existing diseases. Lean individuals might not see a doctor until their disease is advanced.
These patients may need to be encouraged to seek medical care in the earlier stages of their diseases.
Obesity is often considered to be a problem only in Western countries because of the low prevalence of obesity in Asian countries. However, our prospective data demonstrate that the impact of overweight and obesity upon medical care costs in Japan is as large as that of Western countries. Furthermore, the prevalence of obesity among the Japanese doubled between 1979 and 1998, especially in men. 31 It is important to understand that obesity is a problem not only in Western countries but also in Japan, and perhaps in other Asian countries where the majority of the world population lives. We believe that excess weight is now a global burden to public health and society among every ethnic group.
